Citation

Autissier E. Clin. J. Oncol. Nurs. 2019; 23(4): 405-410.

Affiliation

Columbia University.

Copyright

(Copyright © 2019, Oncology Nursing Press)

DOI

10.1188/19.CJON.405-410

PMID

31322611

Abstract

BACKGROUND: Chemotherapy-induced peripheral neuropathy (CIPN) is a debilitating and degenerative side effect of many commonly used chemotherapy agents. Symptoms manifest as sensory and motor neuropathies. CIPN may necessitate chemotherapy dose reduction or discontinuation.

OBJECTIVES: This review intends to summarize literature linking CIPN to an increased risk of falls and injuries and provides recommendations to help maintain patient safety and maximize physical function.

METHODS: A literature search was conducted using MEDLINE®, PubMed®, and ScienceDirect.

FINDINGS: Assessment of CIPN and CIPN-related falls and injuries is vital in preventing related complications, and proper education of oncology nursing staff on CIPN assessment and management is necessary.

Language: en

Keywords

chemotherapy-induced peripheral neuropathy; falls; functional impairment